Applied Optoelectronics, Inc. v. Accelight Technologies, Inc.

District Court, N.D. California·Decided April 23, 2025·No. 4:24-cv-09041·Unknown

Opinion

APPLIED OPTOELECTRONICS, INC., Case No. 24-cv-09041-HSG

Plaintiff, ORDER DENYING DEFENDANT ACCELIGHT TECHNOLOGIES, INC.'S v. MOTION TO DISMISS

ACCELIGHT TECHNOLOGIES, INC., Re: Dkt. No. 24 Defendant.

Pending before the Court is Defendant Accelight Technologies, Inc.’s (“Defendant”) motion to dismiss Plaintiff Applied Optoelectronics, Inc.’s (“Plaintiff’) first amended complaint (“FAC”). Dkt. No. 24 (“Mot.”). The Court finds this matter appropriate for disposition without oral argument and takes it under submission. See Civil L.R. 7-1(b). For the following reasons, the Court DENIES Defendant’s motion. Plaintiff filed this case on December 13, 2024. Dkt. No. 1. Defendant moved to dismiss Plaintiff’s complaint on February 6, 2025, and Plaintiff subsequently filed its FAC on February 19, 2025. Dkt. No. 21 (“FAC”). The FAC accuses Defendant of infringing U.S. Patent Nos. 9,523,826 (the “’826 Patent”), 10,042,116 (the “’116 Patent”), 9,448,367 (the “’367 Patent”), 10,379,301 (the “’301 Patent”), 10,313,024 (the “’024 Patent”), and 10,788,690 (the “’690 Patent”) (collectively, the “Asserted Patents”).1 Dkt. No. 21 (“FAC”) ¶ 4. Plaintiff specifically

1 Plaintiff’s initial complaint accused Defendant of direct infringement under both a literal and doctrine of equivalents (“DOE”) theory. See Dkt. No. 1 ¶¶ 20–72. The initial complaint also accused Defendant of induced and contributory infringement under 35 U.S.C. § 271(b) and (c). alleges that five of Defendant’s products infringe the Asserted Patents: (1) 100G QSFP LR4, (2) 100G QSFP28 CWDM4, (3) 400G QSFP-DD SR8, (4) 400G QSFP-DD FR4, and (5) 400G QSFP-DD DR4 (collectively, the “Accused Products”). Id. ¶ 18. Attached as exhibits to the FAC are eight claim charts mapping Plaintiff’s infringement allegations for: (1) the 100G QSFP LR4 product against the ’826 and ’024 Patents; (2) the 100G QSFP28 CWDM4 product against the ’826, ’116, and ’301 Patents; (3) the 400G QSFP-DD SR8 product against the ’826 Patent; (4) the 400G QSFP-DD FR4 product against the ’367 Patent’; and (5) the 400G QSFP-DD DR4 product against the ’690 Patent. Id., Exs. G–N. Federal Rule of Civil Procedure 8(a) requires that a complaint contain “a short and plain statement of the claim showing that the pleader is entitled to relief.” Fed. R. Civ. P. 8(a)(2). A defendant may move to dismiss a complaint for failing to state a claim upon which relief can be granted under Rule 12(b)(6). “Dismissal under Rule 12(b)(6) is appropriate only where the complaint lacks a cognizable legal theory or sufficient facts to support a cognizable legal theory.” Mendiondo v. Centinela Hosp. Med. Ctr., 521 F.3d 1097, 1104 (9th Cir. 2008). To survive a Rule 12(b)(6) motion, a plaintiff need only plead “enough facts to state a claim to relief that is plausible on its face.” Bell Atl. Corp. v. Twombly, 550 U.S. 544, 570 (2007). A claim is facially plausible when a plaintiff pleads “factual content that allows the court to draw the reasonable inference that the defendant is liable for the misconduct alleged.” Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009). In reviewing the plausibility of a complaint, courts “accept factual allegations in the complaint as true and construe the pleadings in the light most favorable to the nonmoving party.” Manzarek v. St. Paul Fire & Marine Ins. Co., 519 F.3d 1025, 1031 (9th Cir. 2008). Nevertheless, courts do not “accept as true allegations that are merely conclusory, unwarranted deductions of fact, or unreasonable inferences.” In re Gilead Scis. Secs. Litig., 536 F.3d 1049, 1055 (9th Cir. 2008) (quoting Sprewell v. Golden State Warriors, 266 F.3d 979, 988 (9th Cir. 2001)). Defendant seeks to dismiss Plaintiff’s “infringement claims for all [A]ccused [P]roducts, at 6.2 Defendant further seeks to preclude Plaintiff from reasserting direct infringement under a DOE theory and indirect infringement. Id. at 13. A. Direct Infringement The FAC includes eight claim charts—three for the ’826 Patent and one for each of the five remaining Asserted Patents—outlining Plaintiff’s infringement allegations for: (1) the ’826 Patent against the 100G QSFP LR4, (2) 100G QSFP28 CWDM4, and (3) 400G QSFP-DD SR8 products; (4) the ’024 Patent against the 100G QSFP LR4 product; (5) the ’116 Patent against the 100G QSFP28 CWDM4 product; (6) the ’301 Patent against the 100G QSFP28 CWDM4 product; (7) the ’367 Patent against the 400G QSFP-DD FR4 product; and (8) the ’690 Patent against the 400G QSFP-DD DR4 product. Id., Exs. G–N. Each Accused Product and each Asserted Patent is charted at least once. Defendant argues that although Plaintiff’s “infringement mappings may be sufficient to draw an inference that at least one claim of each Asserted Patent is practiced by the product that is actually charted for that patent . . . the FAC does not provide sufficient facts to support this allegation for the non-charted Accused Products.” Id. at 9. Defendant argues that Plaintiff “has not provided sufficient allegations for the Court to plausibly infer that all the Accused Products, which fall into different categories of transceiver modules, meet at least one claim of each Asserted Patent.” Id. at 10. “To plead direct infringement, a plaintiff must recite ‘some factual allegations that, when taken as true, articulate why it is plausible that the accused product infringes the patent claim.’” Estech Sys. IP, LLC v. Intermedia.net, Inc., No. 24-CV-02526-EJD, 2025 WL 834500, at *4 (N.D. Cal. Mar. 17, 2025) (quoting Bot M8 LLC v. Sony Corp. of Am., 4 F.4th 1342, 1353 (Fed. Cir. 2021)). “To satisfy the Iqbal pleading standard in a patent case, ‘[s]pecific facts are not necessary.’” Id. (quoting Disc Disease Sols. Inc. v. VGH Sols., Inc., 888 F.3d 1256, 1260 (Fed. Cir. 2018)). “The complaint needs to only give a defendant ‘fair notice of what the [infringement] claim is and the ground upon which it rests.’” Id. (quoting Disc Disease Sols. Inc., 888 F.3d at 1260). “[T]his District generally has not required detailed infringement theories until the time that infringement contentions are served, which is typically several months after a complaint has been filed.” Fortinet, Inc. v. Forescout Techs., Inc., No. 20-CV-03343-EMC, 2020 WL 6415321, at *11 (N.D. Cal. Nov. 2, 2020). The Court finds the FAC adequately pleads direct infringement. Plaintiff has specifically identified the five Accused Products—all of which are transceiver modules—and the Asserted Patents all generally relate to optical communications components, including optical transceiver modules. See FAC, Ex. A at 1:15–17 (’826 Patent “relates to an optical communications component, more particularly to a pluggable optical transceiver module”); id., Ex. B at 1:10–13 (’116 Patent “relates to optical transceiver modules”); id., Ex. C at 1:15–20 (’367 Patent “relates to optical transceiver modules”); id., Ex. D at 1:5–8 (’301 Patent “relates to fiber optical communications, and more partic

Free access — add to your briefcase to read the full text and ask questions with AI

Applied Optoelectronics, Inc. v. Accelight Technologies, Inc., (N.D. Cal. 2025).

Applied Optoelectronics, Inc. v. Accelight Technologies, Inc. (Applied Optoelectronics, Inc. v. Accelight Technologies, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Manzarek v. St. Paul Fire & Marine Insurance
519 F.3d 1025 (Ninth Circuit, 2008)
Mendiondo v. Centinela Hospital Medical Center
521 F.3d 1097 (Ninth Circuit, 2008)
In Re Gilead Sciences Securities Litigation
536 F.3d 1049 (Ninth Circuit, 2008)
Disc Disease Solutions Inc. v. Vgh Solutions, Inc.
888 F.3d 1256 (Federal Circuit, 2018)
Bot M8 LLC v. Sony Corporation of America
4 F.4th 1342 (Federal Circuit, 2021)
Sprewell v. Golden State Warriors
266 F.3d 979 (Ninth Circuit, 2001)
Windy City Innovations, LLC v. Microsoft Corp.
193 F. Supp. 3d 1109 (N.D. California, 2016)